Hoth Therapeutics Inc. has announced that it received a notification from The Nasdaq Stock Market regarding non-compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The company's common stock has been trading below the required $1.00 per share minimum bid price for 30 consecutive business days, as per Nasdaq Listing Rule 5550(a)(2). As a result, Hoth Therapeutics has been given 180 calendar days, until November 10, 2025, to rectify this issue by achieving a closing bid price of at least $1.00 per share for 10 consecutive business days. If unable to meet this deadline, the company may be eligible for an additional 180-day compliance period, provided it meets other listing requirements and submits a plan to address the deficiency. Hoth Therapeutics is exploring options, including a potential reverse stock split, to meet the Nasdaq requirements and maintain its listing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.